The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl 4 -Induced Liver Fibrosis in Rats.

MLA

Ghobrial, Diana K., et al. “The Role of Pyrazolo[3,4-d]Pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl 4 -Induced Liver Fibrosis in Rats.” Antioxidants, vol. 12, no. 3, Mar. 2023, p. 637. EBSCOhost, https://doi.org/10.3390/antiox12030637.

APA

Ghobrial, D. K., El-Nikhely, N., Sheta, E., Ragab, H. M., Rostom, S. A. F., Saeed, H., & Wahid, A. (2023). The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl 4 -Induced Liver Fibrosis in Rats. Antioxidants, 12(3), 637. https://doi.org/10.3390/antiox12030637

Chicago

Ghobrial, Diana K., Nefertiti El-Nikhely, Eman Sheta, Hanan M. Ragab, Sherif A. F. Rostom, Hesham Saeed, and Ahmed Wahid. 2023. “The Role of Pyrazolo[3,4-d]Pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl 4 -Induced Liver Fibrosis in Rats.” Antioxidants 12 (3): 637. doi:10.3390/antiox12030637.